Accessibility Menu
Zynex Stock Quote

Zynex (NASDAQ: ZYXI)

$1.42
(3.7%)
+0.05
Price as of October 21, 2025, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$1.42
Daily Change
(3.7%) +$0.05
Day's Range
$1.36 - $1.47
Previous Close
$1.42
Open
$1.39
Beta
1.26
Volume
177,521
Average Volume
232,593
Market Cap
43M
Market Cap / Employee
$1.42M
52wk Range
$1.23 - $9.42
Revenue
-
Gross Margin
0.75%
Dividend Yield
N/A
EPS
-$0.94
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Zynex Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
ZYXI-83.03%-88.92%-35.6%+23%
S&P+15.06%+95.03%+14.29%+485%

Zynex Company Info

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. It also develops a new blood volume monitor for use in hospitals and surgery centers. The company was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$22.29M-55.3%
Gross Profit$15.24M-61.8%
Gross Margin68.35%-11.7%
Market Cap$78.02M-73.7%
Market Cap / Employee$0.08M0.0%
Employees1K-9.1%
Net Income-$20.03M-1746.1%
EBITDA-$9.25M-373.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$17.54M-43.2%
Accounts Receivable$10.35M-56.2%
Inventory12.2-20.7%

Liabilities

Q2 2025YOY Change
Long Term Debt$8.88M-87.5%
Short Term Debt$63.58M1446.2%

Ratios

Q2 2025YOY Change
Return On Assets-27.58%-32.0%
Return On Invested Capital12.53%-7.6%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$6.23M-724.8%
Operating Free Cash Flow-$6.20M-646.7%

Valuation

MetricQ1 2024Q2 2024Q3 2024Q4 2024YoY Change
Price to Earnings54.7153.7555.1486.13111.72%
Price to Book7.897.131.963.75-58.18%
Price to Sales1.351.330.400.54-65.22%
Price to Tangible Book Value54.9632.308.70-11.73-118.82%
Price to Free Cash Flow TTM24.0317.2816.7921.05-4.89%
Enterprise Value to EBITDA60.82340.70-9.89-14.38-114.13%
Free Cash Flow Yield4.2%5.8%6.0%4.8%5.14%
Return on Equity10.2%7.3%-27.5%-168.2%-1424.95%
Total Debt$74.68M$73.82M$73.04M$72.46M-3.35%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.